Generic Oncology Drugs Market Size, Scope, and Share by 2031
Generic Oncology Drugs Market: Strategic Insights
Generic Oncology Drugs Market
-
CAGR (2023 - 2031)6.3% -
Market Size 2022
US$ 24.78 Billion -
Market Size 2031
US$ 42.43 Billion
Market Dynamics
GROWTH DRIVERS
- Increasing Prevalence of Cancer
FUTURE TRENDS
- Inclination Towards Personalized Medicines
OPPORTUNITIES
- Growing Preference for Generic drugs
Key Players
- Teva Pharmaceutical Industries LTD
- Sandoz International GMBH
- Glenmark Pharmaceuticals LIMITED
- Sun Pharmaceutical Industries LTD
- MSN Laboratories
- Aurobindo Pharma
- Intas Pharmaceuticals LTD
- Zydus Cadila
- Mylan N V
- Shilpa Medicare LTD
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Molecular Type - Large Molecule
- Small Molecule
Indication - Lung Cancer
- Stomach Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Liver Cancer
- Kidney Cancer
- Cervical Cancer
Get Free Sample For